Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
On par with many of my repositories, this one didn’t start off with great ambition either. It was merely an archive of LeetCode problems and solutions. For a problem like edit distance, there are two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback